Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Lupus Nephritis

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Lupus Nephritis:

Pubmed Logo
Circulating CSF-1 Promotes Monocyte and Macrophage Phenotypes that Enhance Lupus Nephritis.
Macrophages mediate kidney disease and are prominent in a mouse model...
21st November, 2009
*Laboratory of Molecular Autoimmune Disease, Renal Division, Brigham and J Am Soc Nephrol. 2009 Nov 19.
DOI Direct Link
Protective role of rheumatoid factor in lupus nephritis.
Macrophages mediate kidney disease and are prominent in a mouse model...
18th November, 2009
Rheumatology Division, Hospital Universitario Evangelico de Curitiba, Clin Exp Rheumatol. 2009 Sep-Oct;27(5):895.
Suppression of tumor necrosis factor receptor associated factor (TRAF)-2 attenuates the proinflammatory and proliferative effect of aggregated IgG on rat renal mesangial cells.
Immune-complex (IC) mediated glomerulonephritis (GN) is a common cause of...
17th November, 2009
Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen Cytokine. 2009 Nov 10.
DOI Direct Link
Mode of inheritance in systemic lupus erythematosus in Saudi multiplex families.
Systemic lupus erythematosus (SLE) is a an autoimmune disease causing...
17th November, 2009
Department of Medical Genetics, King Faisal Specialist Hospital and Genet Couns. 2009;20(3):215-23.
Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus.
Patients with systemic lupus erythematosus (SLE) are susceptible to the...
10th November, 2009
Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Lupus. 2009 Nov 6.
DOI Direct Link

View more research publications.

Press Releases About Lupus Nephritis:

BioPortfolio Logo
Oklahoma Medical Research Foundation Accelerates Discovery With Isilon IQ 18th November, 2009 Isilon Systems
SEATTLE, Nov. 18 /PRNewswire-FirstCall/ -- IsilonĀ® Systems (Nasdaq: ISLN) today announced that the Oklahoma Medical Research Foundation (OMRF), a nonprofit biomedical research institute, has
FDA Clears SQI's Automated SQiDworks Diagnostics Platform and IgXPLEX Rheumatoid Arthritis Assay for Sale in the United States 2nd November, 2009 SQI Diagnostics Inc.
TORONTO, Nov. 2 /PRNewswire-FirstCall/ - SQI Diagnostics Inc. (TSX-V: SQD), a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that the U.S.
Promise of a New Lupus Treatment Is a Groundbreaking Achievement 2nd November, 2009 Lupus Foundation of America
BENLYSTA(TM) Successful in Second Pivotal Clinical Trial WASHINGTON, Nov. 2 /PRNewswire-USNewswire/ -- Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS
Lupus Research Institute: Benlysta(TM) Trial Results in an Historic Research Breakthrough and Victory for People With Lupus 2nd November, 2009 Lupus Research Institute
Second successful phase III trial points to the first new lupus treatment in over 5O years. NEW YORK, Nov. 2 /PRNewswire-USNewswire/ -- The Lupus Research Institute (LRI) and its National Coalition of
Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment 26th October, 2009 Reportlinker
-- A focus on "engineered" antibodies Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment reviews the broad drug development effort that is focused on bringing

BioNews Results for Lupus Nephritis:

RSS Logo
BioPortfolio Logo
Circulating CSF-1 Promotes Monocyte and Macrophage Phenotypes that Enhance Lupus Nephritis
MDLinx:  Nov 20 2009 12:24PM Matching: lupus nephritis
Clinical-Pathological Features and Prognosis of Thrombotic Thrombocytopenic Purpura in Patients With Lupus Nephritis
MDLinx:  Nov 13 2009 11:52AM Matching: lupus nephritis
Biomarkers for Lupus Nephritis: The Quest Continues
MDLinx:  Nov 13 2009 11:52AM Matching: lupus nephritis
Medical News: Lupus Patients Who Receive Kidney Transplants Rarely Develop Lupus Nephritis
Medical News Today:  Nov 2 2009 2:49PM Matching: lupus nephritis
Lupus Patients Who Receive Kidney Transplants Rarely Develop Lupus Nephritis
Medical News Today:  Nov 2 2009 12:40PM Matching: lupus nephritis
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Lupus Nephritis Patents:

USPTO Logo
US Patent No.Title
7517657 Peptides for detecting anti-double stranded DNA antibody and uses thereof
7544487 Fusion proteins containing recombinant cytotoxic RNAses
7544782 Tumour necrosis factor binding ligands
7547437 Method of treating fibrosis
7550143 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Lupus Nephritis scientists - we have details of around 442 individuals working on Lupus Nephritis .


This page has been viewed 430 times
Recent Search Terms used to find this page: groundbreaking medicine for lupus | lupus nephritis pdf 2009 | lupus nephritis pdf 2009 | lupus nephritis 2009 | lupus nephritis | lupus nephritis | is there any cure for lupus nephritis | nephritis supporters | lupus nephritis publications | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Lupus Nephritis across BioPortfolio, or for Lupus Nephritis Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.